Bvf
Latest statistics and disclosures from Bvf Inc/il's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Merus N V, Springworks Therapeutics Inc, Ionis Pharmaceuticals, Ac Immune Sa shs, Cytokinetics, and represent 31.91% of Bvf Inc/il's stock portfolio.
- Added to shares of these 10 stocks: Springworks Therapeutics Inc (+$61.66M), Ionis Pharmaceuticals (+$56.05M), Galapagos Nv-spon (+$46.57M), Glycomimetics (+$31.73M), Deciphera Pharmaceuticals Inc (+$24.12M), Ac Immune Sa shs (+$19.02M), Ideaya Biosciences Inc (+$12.97M), Calithera Biosciences (+$11.52M), Akero Therapeutics Inc (+$10.73M), Prevail Therapeutics Ord (+$8.06M).
- Started 17 new stock positions in X4 Pharmaceuticals Inc, Ionis Pharmaceuticals, Glycomimetics, Novus Therapeutics, Gamida Cell Ltd adr, Brickell Biotech Inc, Sutro Biopharma Inc, Deciphera Pharmaceuticals Inc, Mereo Biopharma Group Plc ads, Aduro Biotech. Galapagos Nv-spon, Ideaya Biosciences Inc, Akero Therapeutics Inc, Biolinerx Ltd sponsored ads, Springworks Therapeutics Inc, Prevail Therapeutics Ord, Genocea Biosciences Inc Com New stock.
- Reduced shares in these 10 stocks: , ARQL (-$30.11M), Concert Pharmaceuticals I equity (-$16.72M), , Argenx Se (-$10.10M), Mirati Therapeutics (-$9.56M), Blueprint Medicines (-$9.36M), Vbi Vaccines (-$8.83M), Kura Oncology (-$7.54M), Voyager Therapeutics (-$5.94M).
- Sold out of its positions in Argenx Se, ARRY, Biolinerx Ltd-spons Adr, Concert Pharmaceuticals I equity, Genocea Biosciences, Oncomed Pharmaceuticals, Realm Therapeutics Plc sponsored ads, Vbi Vaccines, Vical, Voyager Therapeutics. Xencor.
- Bvf Inc/il was a net buyer of stock by $143.30M.
- Bvf Inc/il has $951.74M in assets under management (AUM), growing by 6.57%.
Companies in the Bvf Inc/il portfolio as of September 2019 quarter
| Company (Ticker) | Portfolio Weight | Share Count | Change in Shares | Price |
|---|---|---|---|---|
| Merus N V | 8.69 | 4.64M | +2% | 17.82 |
| Springworks Therapeutics Inc | 6.48 | 2.84M | NEW | 21.68 |
| Ionis Pharmaceuticals | 5.89 | 935548 | NEW | 59.91 |
| Ac Immune Sa shs | 5.88 | 11.30M | +51% | 4.95 |
| Cytokinetics | 4.98 | 4.17M | +9% | 11.38 |
| Galapagos Nv-spon | 4.89 | 305076 | NEW | 152.66 |
| Xoma Corp Del Com New stock | 3.69 | 1.80M | 19.52 | |
| Arcus Biosciences Incorporated | 3.42 | 3.58M | +27% | 9.10 |
| Blueprint Medicines | 3.38 | 437565 | -22% | 73.47 |
| Glycomimetics | 3.33 | 7.36M | NEW | 4.31 |
| Kura Oncology | 3.19 | 2.00M | -19% | 15.17 |
| Replimune Group Inc | 2.56 | 1.75M | +8% | 13.90 |
| Mirati Therapeutics | 2.53 | 308984 | -28% | 77.91 |
| Deciphera Pharmaceuticals Inc | 2.53 | 710697 | NEW | 33.94 |
| Molecular Templates Inc | 2.34 | 3.38M | -5% | 6.59 |
| Calithera Biosciences | 2.19 | 6.75M | +123% | 3.09 |
| Pieris Pharmaceuticals | 1.92 | 5.35M | +31% | 3.41 |
| Infinity Pharmaceuticals (INFI) | 1.89 | 17.43M | 1.03 | |
| Dicerna Pharmaceuticals | 1.85 | 1.22M | -12% | 14.36 |
| Xenon Pharmaceuticals | 1.65 | 1.74M | -2% | 9.01 |
| ArQule (ARQL) | 1.59 | 2.11M | -66% | 7.17 |
| Five Prime Therapeutics | 1.53 | 3.77M | +22% | 3.87 |
| Cytomx Therapeutics | 1.46 | 1.88M | +56% | 7.38 |
| Syndax Pharmaceuticals | 1.39 | 1.76M | -11% | 7.47 |
| Ideaya Biosciences Inc | 1.36 | 1.44M | NEW | 9.00 |
| Anaptysbio Inc Common | 1.30 | 353818 | +60% | 34.99 |
| Akero Therapeutics Inc | 1.13 | 471746 | NEW | 22.75 |
| Spero Therapeutics Inc | 1.05 | 939704 | +103% | 10.60 |
| Chemocentryx | 1.01 | 1.41M | -3% | 6.78 |
| Corvus Pharmaceuticals | 0.96 | 3.05M | +44% | 3.01 |
| Essa Pharma Inc | 0.93 | 2.64M | +354% | 3.37 |
| Galmed Pharmaceuticals Ltd shs | 0.92 | 1.83M | -2% | 4.78 |
| Protagonist Therapeutics Inc Com stock | 0.86 | 682630 | -39% | 12.01 |
| Prevail Therapeutics Ord | 0.85 | 656483 | NEW | 12.28 |
| Verastem | 0.80 | 6.33M | +80% | 1.21 |
| Ovid Therapeutics | 0.79 | 2.32M | -29% | 3.24 |
| X4 Pharmaceuticals Inc | 0.79 | 593474 | NEW | 12.71 |
| Forward Pharma A/s | 0.69 | 6.48M | -23% | 1.02 |
| Mersana Therapeutics | 0.67 | 4.04M | +61% | 1.58 |
| Genocea Biosciences Inc Com New stock | 0.64 | 2.10M | NEW | 2.90 |
| Cti Biopharma | 0.60 | 6.93M | 0.83 | |
| Eiger Biopharmaceuticals | 0.58 | 539512 | -20% | 10.25 |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.56 | 2.69M | +57% | 1.99 |
| Spring Bk Pharmaceuticals In | 0.51 | 1.38M | +44% | 3.50 |
| Biolinerx Ltd sponsored ads | 0.48 | 1.73M | NEW | 2.64 |
| Sunesis Pharmaceuticals Inc Ne | 0.47 | 6.19M | +170% | 0.72 |
| Alpine Immune Sciences | 0.47 | 1.14M | -5% | 3.92 |
| Gamida Cell Ltd adr | 0.45 | 1000000 | NEW | 4.33 |
| Mei Pharma | 0.39 | 2.22M | -17% | 1.68 |
| Sutro Biopharma Inc | 0.33 | 344196 | NEW | 9.09 |
| Erytech Pharma Sa adr | 0.29 | 625000 | 4.44 | |
| Surface Oncology Inc | 0.16 | 1.09M | +140% | 1.42 |
| Mereo Biopharma Group Plc ads | 0.16 | 523382 | NEW | 2.90 |
| Regulus Therapeutics Inc | 0.15 | 2.04M | +93% | 0.72 |
| Aduro Biotech | 0.11 | 1.01M | NEW | 1.06 |
| Brickell Biotech Inc | 0.10 | 228093 | NEW | 4.15 |
| Contrafect | 0.07 | 1.90M | 0.36 | |
| Albireo Pharma | 0.06 | 29000 | -85% | 20.00 |
| Novus Therapeutics | 0.05 | 828876 | NEW | 0.63 |
Download CSV 
Past 13F-HR SEC Filings by Bvf Inc/il
- Bvf Inc/il 2019 Q1 filed May 15, 2019
- Bvf Inc/il 2018 Q4 filed Feb. 14, 2019
- Bvf Inc/il 2018 Q3 filed Nov. 14, 2018
- Bvf Inc/il 2018 Q2 filed Aug. 14, 2018
- Bvf Inc/il 2018 Q1 filed May 7, 2018
- Bvf Inc/il 2017 Q4 filed Feb. 14, 2018
- Bvf Inc/il 2017 Q3 filed Nov. 14, 2017
- Bvf Inc/il 2017 Q2 filed Aug. 14, 2017
- Bvf Inc/il 2017 Q1 filed May 15, 2017
- Bvf Inc/il 2016 Q4 filed Feb. 14, 2017
- Bvf Inc/il 2016 Q3 filed Nov. 14, 2016
- Bvf Inc/il 2016 Q2 filed Aug. 15, 2016
- Bvf Inc/il 2016 Q1 filed May 16, 2016
- Bvf Inc/il 2015 Q4 filed Feb. 16, 2016
- Bvf Inc/il 2015 Q3 filed Nov. 16, 2015
- Bvf Inc/il 2015 Q2 filed Aug. 14, 2015
- Bvf Inc/il 2015 Q1 filed May 15, 2015
- Bvf Inc/il 2014 Q4 filed Feb. 17, 2015
- Bvf Inc/il 2014 Q3 filed Nov. 14, 2014